Real-World Data from the Use of Ranolazine in Patients with Stable Angina Pectoris: The RANGER Study

Real-World Data from the Use of Ranolazine in Patients with Stable Angina Pectoris: The RANGER Study

<b>Background</b>: Although ranolazine has been available for years as a second-line treatment to reduce angina attacks in patients with stable angina pectoris, real-world data on the effectiveness, tolerability, and safety of ranolazine are limited. <b>Methods</b>: A non-int...

Full description

Bibliographic Details
Main Authors: Christoforos Olympios, Panagiotis Stafylas, Alkiviadis Dermitzakis, Ioannis Efthimiadis, Alexandros Gardikiotis, Stavros Kakouros, Stylianos Lampropoulos, John Barbetseas, Angelos Sourgounis, on behalf of RANGER Investigators
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Journal of Clinical Medicine
Subjects:
ranolazine
antianginal medicine
angina pectoris
coronary artery disease
real-world data
Online Access:https://www.mdpi.com/2077-0383/13/6/1672

Similar Items

Similar Items